A new haemodialysis therapy that has the potential to significantly advance renal care for patients in New Zealand has won the James & Wells Medical Technology Association of New Zealand (MTANZ) Innovation Award for 2018.
Check out the Scoop article
Baxter Healthcare received the award for its HDx enabled by Theranova haemodialysis therapy from Jonathan Lucas, partner at James & Wells, at the Health Tech Week Gala Dinner.
Theranova is an innovative dialyser. It more closely mimics the natural kidney compared with other dialysis membranes. Theranova extends the range of toxins that can be filtered from the blood during haemodialysis for the first time without significant albumin loss.
This technology is unique in New Zealand and global markets. The therapy is designed to work with all haemodialysis machines. This allows clinics to offer HDx therapy using existing resources and staff.
“MTANZ believes these awards, which are open to both imported and locally developed medical technology, show the tremendous innovation in the NZ health technology market. Innovation is so essential to deliver better outcomes for patients and improve efficiencies in the NZ healthcare system,” says MTANZ chief executive Faye Sumner, CNZM.